C. UYSAL Et Al. , "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression," THERAPEUTIC APHERESIS AND DIALYSIS , 2024
UYSAL, C. Et Al. 2024. The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression. THERAPEUTIC APHERESIS AND DIALYSIS .
UYSAL, C., Koyuncu, S., Ipekten, F., KARAKÜKCÜ, Ç., & KOÇYİĞİT, İ., (2024). The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression. THERAPEUTIC APHERESIS AND DIALYSIS .
UYSAL, CİHAN Et Al. "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression," THERAPEUTIC APHERESIS AND DIALYSIS , 2024
UYSAL, CİHAN Et Al. "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression." THERAPEUTIC APHERESIS AND DIALYSIS , 2024
UYSAL, C. Et Al. (2024) . "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression." THERAPEUTIC APHERESIS AND DIALYSIS .
@article{article, author={CİHAN UYSAL Et Al. }, title={The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression}, journal={THERAPEUTIC APHERESIS AND DIALYSIS}, year=2024}